RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles

Displaying items 34-42
  • Doctors draw payments from drug companies

    Doctors draw payments from drug companies
    Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...
  • Some drugs raising red flags

    At drug company-sponsored seminars, Illinois doctors are speaking about dozens of commonly prescribed medications that help millions of patients. But questions have been raised about some of the drugs: •Atypical antipsychotics such as Zyprexa (...
  • Doctor-drug company database adds to confusion for consumers

    Doctor-drug company database adds to confusion for consumers
    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues. He found several doctors who had potentially compromising...
  • Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns

    Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
    About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...
  • Newer antipsychotics overused, US study suggests

    Newer antipsychotics overused, US study suggests
    Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday. The drugs, known as "atypical...
  • FDA panel recommends wider use for cholesterol-lowering drug Crestor

     
    A Food and Drug Administration advisory panel recommended today that drug-maker AstraZeneca be allowed to expand the labeling on its cholesterol-lowering drug Crestor to include some people who do not have high cholesterol levels. That could allow as many...
  • PhRMA taps Castellani as new CEO

     
    by Mike Memoli The top pharmaceutical group has named John Castellani, most recently president of the Business Roundtable, as it's new president and CEO, effective September 1. He replaces Billy Tauzin, the former Louisiana Congressman who held one of...
  • Pharma cases drive U.S. Attorney's collections

     
    The U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it...
  • AstraZeneca to pay $68.5 million in Seroquel settlement

     
    California Atty. Gen. Kamala D. Harris on Thursday announced a $68.5-million multistate settlement with AstraZeneca Pharmaceuticals after the states sued the company for allegedly using unfair and deceptive marketing practices for its antipsychotic drug...